Toward a shared vision for cancer genomic data

New England Journal of Medicine

Volumn 375, Issue 12, 2016, Pages 1109-1112

  Grossman, Robert L ^a   Heath, Allison P ^a   Ferretti, Vincent ^b   Varmus, Harold E ^c   Lowy, Douglas R ^d   Kibbe, Warren A ^d   Staudt, Louis M ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER RESEARCH; CLINICAL STUDY; COPY NUMBER VARIATION; DATA ANALYSIS; GENE EXPRESSION; GENOME; GENOME ANALYSIS; GENOMIC DATA COMMONS; HUMAN; INFORMATION SYSTEM; NATIONAL HEALTH ORGANIZATION; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION; REVIEW; GENETICS; HUMAN GENOME; INFORMATION PROCESSING; NEOPLASM; PERSONALIZED MEDICINE; UNITED STATES;

DNA;

DATASETS AS TOPIC; DNA, NEOPLASM; GENOME, HUMAN; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; PRECISION MEDICINE; UNITED STATES;

EID: 84988850450     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1607591     Document Type: Review

References (5)

1. Lawrence MS, Stojanov P, Mermel CH, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505: 495-501.
2. Shaw AT, Ou S-HI, Bang Y-J, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med 2014; 371: 1963-71.
3. Larkin J, Ascierto PA, Dréno B, et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med 2014; 371: 1867-76.
4. Wilson WH, Young RM, Schmitz R, et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med 2015; 21: 922-6.
5. Taichman DB, Backus J, Baethge C, et al. Sharing clinical trial data-a proposal from the International Committee of Medical Journal Editors. N Engl J Med 2016; 374: 384-6.